Click here to go to the previous page
Program Code:
9217-S
Date:
Sunday, October 13, 2013
Time:
2:00 PM to 3:30 PM
EST
SPEAKER
(S):
Steven Spitalnik, MD, Professor, Columbia University
France Noizat-Pirenne, MD, PhD, Medical Director and Scientific Director, Etablissement Franais du Sang, Ile de France
Robin van Bruggen, PhD, Senior Scientist, Sanquin
Description
Donor red blood cells are destroyed following transfusion if the patient has or develops clinically significant antibodies. However, some patients, especially those with sickle cell disease (SCD) can experience life threatening transfusion reactions despite lack of clinically relevant antibodies. Besides Fc receptors, other immunoreceptors on macrophages such as SIRP-alpha receptor have the potential to mediate red cell clearance. A hyperactivated immune state as a result of the underlying disease may also contribute to increased RBC destruction. In this session, we will review some of the possible mechanisms of red blood cells clearance following transfusion, describe the role of various macrophage molecules in red cell destruction and highlight use of mouse models of hemolytic transfusion reactions to dissect the mechanisms of RBC clearance in order to develop strategies to stop the destruction.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.